HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Dega-type osteotomy after closure of the triradiate cartilage in non-walking patients with severe cerebral palsy.

Abstract
A total of 47 non-walking patients (52 hips) with severe cerebral palsy and with a mean age of 14 years, (9 to 27) underwent a Dega-type pelvic osteotomy after closure of the triradiate cartilage, together with a derotation varus-shortening femoral osteotomy and soft-tissue correction for hip displacement which caused pain and/or difficulties in sitting. The mean follow-up was 48 months (12 to 153). The migration percentage improved from a pre-operative mean of 70% (26% to 100%) to 10% (0% to 100%) post-operatively. In five hips the post-operative migration percentage was greater than 25%, which was associated with continuing pain in two patients. Three patients had persistent hip pain and a migration percentage less than 25%. In five hips a fracture through the acetabulum occurred, and in another there was avascular necrosis of the superior acetabular segment, but these had no adverse effect on functional outcome. We conclude that it is possible to perform a satisfactory pelvic osteotomy of this type in these patients after the triradiate cartilage has been closed.
AuthorsJ E Robb, R Brunner
JournalThe Journal of bone and joint surgery. British volume (J Bone Joint Surg Br) Vol. 88 Issue 7 Pg. 933-7 (Jul 2006) ISSN: 0301-620X [Print] England
PMID16798999 (Publication Type: Journal Article)
Topics
  • Acetabulum
  • Adolescent
  • Adult
  • Arthroplasty, Replacement, Hip (methods)
  • Cartilage, Articular (surgery)
  • Cerebral Palsy (complications, physiopathology, surgery)
  • Child
  • Femur (surgery)
  • Hip Dislocation (etiology, physiopathology, surgery)
  • Hip Joint (physiopathology, surgery)
  • Humans
  • Osteotomy (methods)
  • Pain (etiology, physiopathology, surgery)
  • Pelvis (surgery)
  • Postoperative Complications
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: